newsfilter
← Latest News
GlobeNewswire·

Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIII

PRINCETON, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (NASDAQ:OYST), ("Oyster Point Pharma", or "the Company"), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in